CTRV News: CMX157 Advances Head-to-Head Phase 2a Clinical Study in Hepatitis B Patients with Favorable Recommendation from DSMB 06:00 AM CTRV News: Current Report Filing (8-k) 10/13/2016 07:13:10 AM CTRV News: CMX157 Demonstrates 99% Viral Load Reduction in Ongoing Head-to-Head Phase 2a Clinical Study Vs. Viread® in Hepatitis B Pati... 10/13/2016 06:00:00 AM CTRV News: Current Report Filing (8-k) 10/03/2016 08:26:21 AM CTRV News: ContraVir to Present at the 15th Annual BIO Investor Forum 10/03/2016 06:00:00 AM News News Alert: CMX157 Advances Head-to-Head Phase 2a Clinical Study in Hepatitis B Patients with Favorable Recommendation from DSMB 10/17/2016 06:00:00 AM